Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2015

Jun 10, 2015

34117_dirs_2015-06-10_5160c932-472f-40f6-851f-f8e091fbaffe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2015-06-09

Reporting Person: BERMAN ROBERT ANDREW (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-06-09 Common Stock P 10000 $0.1399 Acquired 688650 Direct
2015-06-10 Common Stock P 10000 $0.1449 Acquired 698650 Direct